Clinical Trial Update: Dose Response Study of Transdermal Human Insulin in Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 dose‑response study of transdermal human insulin for diabetes is underway, with the trial currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Transdermal Human Insulin (human insulin)

Snippet

Sponsor: Transdermal Delivery Solutions Corp | Conditions: Glucose, High Blood | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING